Actualités Amryt Pharma Plc - AMYT | Actions London Stock Exchange

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Amryt Pharma plc Amryt Submits A New Drug Application To The Us Food And Drug Administration For Oleogel-S10* (Filsuvez(R))

T DUBLIN, Ireland, and Boston MA, March 31, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company...

Amryt Pharma plc Amryt Announces Results From An Investigator Sponsored Study Of Lomitapide In Fcs

T DUBLIN, Ireland, and Boston MA, March 30, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company...

Amryt Pharma plc Amryt Announces Validation Of Its Maa By The Ema For Oleogel-S10*(Filsuvez(R))

T DUBLIN, Ireland, and Boston MA, March 29, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company focussed...

IN BRIEF: Amryt gets positive feedback on Myalept from US regulator

- biopharmaceutical company - Receives positive feedback from the US Food & Drug Administration on the path forward fo ...

Amryt Pharma plc Amryt Receives Positive Feedback From The Fda On The Path Forward For Myalept(R) (metreleptin) Indication In...

T Amryt Receives Positive Feedback from the FDA on the Path Forward for Myalept(R) (metreleptin) Indication in Partial Lipodystrophy DUBLIN...

IN BRIEF: Amryt's Myalepta secures reimbursement approval in France

- biopharmaceutical company - Says the French Ministry of Social Affairs & Health has approved Myalepta for reimbursem ...

Amryt Pharma plc Amryt Receives Reimbursement Approval From The French Ministry Of Social Affairs And Health For Myalepta(R) ...

T Amryt Receives Reimbursement Approval from the French Ministry of Social Affairs and Health for Myalepta(R) (metreleptin) DUBLIN, Ireland, and...

Amryt Pharma plc Director/Pdmr Shareholding

T Amryt Pharma plc Director/PDMR Shareholding The following notification is made in accordance with the requirements of the EU Market Abuse...

Amryt Pharma plc Exercise Of Options And Total Voting Rights

T Exercise of Options and Total Voting Rights DUBLIN, Ireland, and Boston MA, March 12, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global...

Amryt Pharma plc Exercise Of Warrants & Issue Of Ordinary Shares And Total Voting Rights

T Exercise of Warrants & Issue of Ordinary Shares and Total Voting Rights DUBLIN, Ireland, and Boston MA, March 11, 2021, Amryt (Nasdaq: AMYT...

IN BRIEF: Amryt, Medison sign distribution deal for Myalepta in Canada

- commercial-stage biopharmaceutical company - Signs a distribution agreement with Medison Pharma Canada to distribute ...

Amryt Pharma plc Director/Pdmr Shareholding

T Grant of Options and Notification of Transactions by Persons Discharging Managerial Responsibilities DUBLIN, Ireland, and Boston MA, March 8...

Amryt Pharma plc Amryt And Medison Pharma Sign Distribution Agreement For Myalepta(R) (metreleptin) In Canada

T Amryt and Medison Pharma Sign Distribution Agreement for Myalepta(R) (metreleptin) in Canada DUBLIN, Ireland, and Boston MA, March 8, 2021...

TRADING UPDATES: Origin Enterprises loss slims; Amryt issues guidance

The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...

Amryt Pharma PLC Amryt Announces Record FY 2020 Results

Amryt Pharma PLC 04 March 2021 Amryt Announces Record FY 2020 Results 18.5% YoY revenue growth to $182.6M (1) 25% YoY revenue growth in...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Amryt Pharma Plc (AMYT)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

AMYT Actualités

Amryt Pharma plc Amryt Submits A New Drug Application To The Us Food And Drug Administration For Oleogel-S10* (Filsuvez(R))

Amryt Pharma plc Amryt Announces Results From An Investigator Sponsored Study Of Lomitapide In Fcs

Amryt Pharma plc Amryt Announces Validation Of Its Maa By The Ema For Oleogel-S10*(Filsuvez(R))

IN BRIEF: Amryt gets positive feedback on Myalept from US regulator

Amryt Pharma plc Amryt Receives Positive Feedback From The Fda On The Path Forward For Myalept(R) (metreleptin) Indication In...

IN BRIEF: Amryt's Myalepta secures reimbursement approval in France

Amryt Pharma plc Amryt Receives Reimbursement Approval From The French Ministry Of Social Affairs And Health For Myalepta(R) ...

Amryt Pharma plc Director/Pdmr Shareholding

Amryt Pharma plc Exercise Of Options And Total Voting Rights

Amryt Pharma plc Exercise Of Warrants & Issue Of Ordinary Shares And Total Voting Rights

IN BRIEF: Amryt, Medison sign distribution deal for Myalepta in Canada

Amryt Pharma plc Director/Pdmr Shareholding

Amryt Pharma plc Amryt And Medison Pharma Sign Distribution Agreement For Myalepta(R) (metreleptin) In Canada

TRADING UPDATES: Origin Enterprises loss slims; Amryt issues guidance

Amryt Pharma PLC Amryt Announces Record FY 2020 Results

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Amryt Pharma Plc (AMYT) Actualités

Amryt Pharma Plc (AMYT)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

AMYT Actualités

Amryt Pharma plc Amryt Submits A New Drug Application To The Us Food And Drug Administration For Oleogel-S10* (Filsuvez(R))

Amryt Pharma plc Amryt Announces Results From An Investigator Sponsored Study Of Lomitapide In Fcs

Amryt Pharma plc Amryt Announces Validation Of Its Maa By The Ema For Oleogel-S10*(Filsuvez(R))

IN BRIEF: Amryt gets positive feedback on Myalept from US regulator

Amryt Pharma plc Amryt Receives Positive Feedback From The Fda On The Path Forward For Myalept(R) (metreleptin) Indication In...

IN BRIEF: Amryt's Myalepta secures reimbursement approval in France

Amryt Pharma plc Amryt Receives Reimbursement Approval From The French Ministry Of Social Affairs And Health For Myalepta(R) ...

Amryt Pharma plc Director/Pdmr Shareholding

Amryt Pharma plc Exercise Of Options And Total Voting Rights

Amryt Pharma plc Exercise Of Warrants & Issue Of Ordinary Shares And Total Voting Rights

IN BRIEF: Amryt, Medison sign distribution deal for Myalepta in Canada

Amryt Pharma plc Director/Pdmr Shareholding

Amryt Pharma plc Amryt And Medison Pharma Sign Distribution Agreement For Myalepta(R) (metreleptin) In Canada

TRADING UPDATES: Origin Enterprises loss slims; Amryt issues guidance

Amryt Pharma PLC Amryt Announces Record FY 2020 Results

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités